Does post-infectious glomerulonephritis (PIGN) typically cause low Complement (C)3, normal or slightly elevated Complement (C)4, and normal Antistreptolysin O (ASO) titers?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Post-Infectious Glomerulonephritis: Complement and Serologic Profile

Post-infectious glomerulonephritis (PIGN) characteristically causes low C3 with normal C4, but ASO titers may be normal in up to 20-30% of cases, particularly when the infection is non-streptococcal or when the patient presents late after the initial infection. 1

Typical Complement Pattern in PIGN

The hallmark laboratory finding in PIGN is low C3 with normal C4, which indicates alternative complement pathway activation rather than classical pathway activation. 1

  • Low C3 is present in approximately 90% of cases at presentation 1
  • C4 typically remains normal, distinguishing PIGN from lupus and other classical pathway disorders 1
  • C3 levels should normalize within 8-12 weeks after disease onset in uncomplicated cases 1
  • Persistently low C3 beyond 12 weeks mandates kidney biopsy to exclude C3 glomerulonephritis (C3GN), which is a distinct disease entity requiring different management 2, 1

ASO Titers: Not Always Elevated

ASO titers are not universally elevated in PIGN, and normal titers do not exclude the diagnosis. 1

  • ASO titers are elevated in only 70-80% of post-streptococcal cases, particularly when pharyngitis was the preceding infection 1
  • Impetigo-associated PIGN has lower rates of ASO elevation because skin infections produce less robust ASO responses 1
  • Non-streptococcal PIGN (from Staphylococcus, pneumococcus, or other organisms) will have normal ASO titers 3, 4
  • Alternative streptococcal antibodies (anti-DNAse B, anti-hyaluronidase) should be measured when ASO is normal but clinical suspicion remains high 2, 1

Clinical Scenario: Low C3, Normal C4, Normal ASO

When you encounter low C3, normal C4, and normal ASO, consider this diagnostic approach:

First: Confirm PIGN Diagnosis

  • Document recent infection history: pharyngitis 1-2 weeks prior or impetigo 4-6 weeks prior 2, 1
  • Obtain anti-DNAse B and anti-hyaluronidase antibodies, which may be positive when ASO is negative 2, 1
  • Culture any active skin or throat infections 2
  • Consider non-streptococcal infections (Staphylococcus aureus, pneumococcus) which cause PIGN with normal ASO 3, 4

Second: Rule Out Alternative Diagnoses

  • Exclude lupus nephritis: check ANA, anti-dsDNA (lupus causes low C3 AND low C4) 1, 5
  • Exclude ANCA vasculitis: check PR3-ANCA and MPO-ANCA 2, 1
  • Exclude anti-GBM disease: check anti-GBM antibodies 2, 1
  • Exclude cryoglobulinemia: check cryoglobulins and rheumatoid factor 2, 1

Third: Monitor for C3GN

  • If C3 remains low beyond 12 weeks, perform kidney biopsy to distinguish PIGN from C3 glomerulonephritis 2, 1
  • C3GN is a distinct disease with ongoing complement dysregulation, poor prognosis, and requires different treatment 6, 7
  • PIGN and C3GN can have overlapping pathologic features on biopsy, but clinical course distinguishes them 7

Common Pitfalls to Avoid

Do not withhold antibiotics even when ASO is normal or infection has resolved—the goal is to reduce antigenic load, not treat active infection. 1

Do not assume normal ASO excludes PIGN—obtain additional streptococcal antibodies and consider non-streptococcal causes. 1, 3

Do not delay kidney biopsy if C3 remains low beyond 12 weeks, as this indicates possible C3GN requiring immunosuppression rather than supportive care alone. 2, 1

Do not use immunosuppression for typical PIGN—the disease is self-limited with excellent prognosis, and corticosteroids are reserved only for severe crescentic disease with rapidly progressive glomerulonephritis. 1

Monitoring Strategy

  • Recheck C3 and C4 every 2-4 weeks initially to confirm normalization trajectory 5
  • Monitor serum creatinine, urinalysis with microscopy, and urine protein-to-creatinine ratio 1
  • If C3 fails to normalize by 8-12 weeks, proceed to kidney biopsy 2, 1
  • Continue monitoring blood pressure and manage hypertension with diuretics and sodium restriction 1

References

Guideline

Management of Post-Streptococcal Glomerulonephritis (PSGN)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Postinfectious glomerulonephritis.

Advances in anatomic pathology, 2012

Guideline

Management of Low Complement C3 and C4 Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the most appropriate next diagnostic step for a 3-year-old girl presenting with progressive edema, recent sore throat, and laboratory findings indicating impaired renal function, including proteinuria, hematuria, and the presence of red blood cell (RBC) casts?
What is the most appropriate next diagnostic step for a 3-year-old girl presenting with progressive edema, recent sore throat, and laboratory findings indicating impaired renal function, including proteinuria and hematuria, with RBC casts?
When does the Complement 3 (C3) level return to normal in a child with acute glomerulonephritis?
A patient with recent pharyngitis, now presenting with hematuria, edema, and hypertension, what is the most likely diagnosis?
What is the appropriate monitoring for a 14-year-old male with proteinuria, recent ear infection, and elevated Anti-Streptolysin O (ASO) titer, currently on amoxicillin, with normal creatinine (Cr) levels, elevated Complement 3 (C3) and Complement 4 (C4) levels, and elevated urine protein-to-creatinine (P:Cr) ratio?
What is CAR-T (Chimeric Antigen Receptor T-cell) therapy for patients with blood cancers, such as acute lymphoblastic leukemia (ALL) or diffuse large B-cell lymphoma (DLBCL)?
What is the recommended citrate anticoagulation protocol for a critically ill patient with acute kidney injury (AKI) requiring Continuous Renal Replacement Therapy (CRRT)?
What is intractable acidosis in critically ill patients with conditions such as diabetic ketoacidosis, lactic acidosis, or renal tubular acidosis?
What is the recommended antibiotic dosage, duration, and frequency for an adult patient with lymphadenitis, with no known allergies or sensitivities?
Is amoxicillin (amoxicillin) suitable for an adult patient with lymphadenitis and no known allergies or sensitivities?
What is the diagnosis and treatment for a patient with dull discomfort and heaviness in the right lower rib area, both front and back, that worsens with sitting, breathing, eating, or drinking, and is reproducible when full?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.